
Release date: 2026-01-09 17:31:12 Article From: Lucius Laos Recommended: 32
Capmatinib slows down or inhibits the spread of cancer cells by blocking a key protein that promotes the growth and proliferation of cancer cells.
The concurrent use of the following drugs with this medicine is generally not recommended, but it may be necessary in certain cases. If both drugs are prescribed together, your doctor may adjust the dosage or frequency of administration of one or both medications.
These drugs include: Abrocitinib, Attenuated Live Adenovirus Type 4 Vaccine, Attenuated Live Adenovirus Type 7 Vaccine, Afatinib, Aliskiren, Alosetron, Alpelisib, Apalutamide, Apixaban, Avacopan, Betrixaban, Bosentan, Carbamazepine, Cenobamate, Cholera Vaccine, Clarithromycin, Clomipramine, Clozapine, Colchicine, Conivaptan, Cyclosporine, Dabigatran Etexilate, Darolutamide, Digoxin, Dofetilide, Doxorubicin, Doxorubicin Hydrochloride Liposome, Duloxetine, Attenuated Live Zaire Ebola Vaccine, Edoxaban, Efavirenz, Elagolix, Ensartinib, Enzalutamide, Etravirine, Everolimus, Fedratinib, Fexinidazole, Fexofenadine and Fosphenytoin.
1. Consume foods that may help alleviate diarrhea (see the Diarrhea section in Side Effect Management).
2. Avoid sun exposure. Use sunscreen with an SPF of 30 (or higher) and wear protective clothing.
3. Alcohol consumption should generally be minimized or avoided entirely. You should discuss this matter with your doctor.
4. Get adequate rest.
5. Maintain good nutrition.
6. Stay active within your capabilities. Gentle exercises such as daily walking are recommended.
7. Be sure to discuss any symptoms or side effects with your medical team. They can prescribe medications and/or provide other recommendations for effectively managing these issues.
Report the following side effects to your medical team immediately once they occur:
1. Allergic reactions: Skin rash, pruritus, urticaria, swelling of the face, lips, tongue or throat.
2. Dry cough, shortness of breath or difficulty breathing.
3. Liver damage: Pain in the upper right abdomen, loss of appetite, nausea, pale-colored stools, dark yellow or brown urine, jaundice (yellowing of the skin or eyes), unusual weakness or fatigue.
4. Pancreatitis: Severe abdominal pain that radiates to the back or worsens after eating or upon palpation, accompanied by fever, nausea and vomiting.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:672025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3662024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:602025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:792025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:742025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:942025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:902025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:932025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: